"Discussions are ongoing with Roche's global pharmaceutical team, based in Switzerland, about how these findings can be more widely applied."
Call it a wild shot....
But whats the chances Roche are investiagting weather these findings offer a better method of delivery for existing drugs in their portfolio as opposed to being thought of as just an avenue for "new drugs".....
Surely any success in reaching targets via intracellular pathways may indeed offer a whole new spectrum within the field - and it is an area that has been so difficult to tap by many.
As previously stated on completeion of the Roche discovery phase - "The Phylogica team has found a number of these entirely new drug carriers. Most have never been indentified before by anyone."
Interesting times
PYC Price at posting:
7.4¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)